AAAAAA

   
Results: 1-8 |
Results: 8
LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS
Authors: KROGER N KRUGER WH GIESEKING F JAENICKE F SCHULTZE W FUSS H MOBUS V KONIGSMANN M BERDEL WE SCHAFERECKERT K WANDT H METZNER B ILLIGER HJ FRICKHOFEN N WULF G WORMANN B KOLBE K HOSSFELD DK MAAS H JONAT W ZANDER AR
Citation: N. Kroger et al., LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 92-92
CYCLOPHOSPHAMIDE THIOTEPA/MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE FOR HIGH-RISK STAGE-II AND STAGE-III BREAST-CANCER/
Authors: KRUGER WH KROGER N KONIGMANN M BERDEL WE FUSS H SCHULTZE W GIESEKING F SCHAFERECKART K MOBUS V FRICKHOFEN N WANDT H ILLIGER HJ METZNER B KOLBE K WORMANN B TRUMPER L HUBER C MAASS H JONAT W ZANDER AR
Citation: Wh. Kruger et al., CYCLOPHOSPHAMIDE THIOTEPA/MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE FOR HIGH-RISK STAGE-II AND STAGE-III BREAST-CANCER/, Bone marrow transplantation, 22, 1998, pp. 31-31
LOW TOXICITY OF HIGH-DOSE CTM FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION FOR HIGH-RISK BREAST-CANCER
Authors: KRUGER WH KROGER N KOLBE K HUBER C GIESEKING F JANICKE F KONIGSMANN M BERDEL WE KERSCHGENS C MAYR AC SCHAFERECKERT K WANDT H SCHULTZE W FUSS H METZNER B ILLIGER HJ FRICKHOFEN N MOBUS V HOSSFELD DK JONAT W ZANDER AR
Citation: Wh. Kruger et al., LOW TOXICITY OF HIGH-DOSE CTM FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION FOR HIGH-RISK BREAST-CANCER, Bone marrow transplantation, 21, 1998, pp. 221-221
FACTORS PREDICTING RESPONSE TO CHEMOENDOCRINE TREATMENT IN ADVANCED BREAST-CANCER
Authors: GIESEKING F MULLER V MAASS H LINDNER C JANICKE F
Citation: F. Gieseking et al., FACTORS PREDICTING RESPONSE TO CHEMOENDOCRINE TREATMENT IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 689-689
HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MP A) THERAPY IN METASTATIC BREAST-CANCER PATIENTS UNDER SPECIAL CONSIDERATION OF MPA SERUM LEVELS -A PROSPECTIVE AND COOPERATIVE STUDY ON THE BASIS OF 178 PATIENTS
Authors: POLLOW K KREIENBERG R MAHLKE M HOFFMANN G POLLOW B SCHAFFRATH M UNTCH M KLOSS W GIESEKING F GOEBE L HEILMANN L STRITTMATTER HJ MELCHERT F KRETSCHMER M
Citation: K. Pollow et al., HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MP A) THERAPY IN METASTATIC BREAST-CANCER PATIENTS UNDER SPECIAL CONSIDERATION OF MPA SERUM LEVELS -A PROSPECTIVE AND COOPERATIVE STUDY ON THE BASIS OF 178 PATIENTS, Tumordiagnostik & Therapie, 18(2), 1997, pp. 43-50
CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER
Authors: KRUGER WH HENNINGS S ASCHENBRENNER M GRUBER M STOCKSCHLADER M GUTENSOHN K LOLIGER C GIESEKING F JONAT W ZANDER AR
Citation: Wh. Kruger et al., CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER, Blood, 88(10), 1996, pp. 999-999
DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER
Authors: KROGER N LEHNERT M MROSS K GIESEKING F THURLIMANN B SCHULLER J KUPPER H HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 361-361
DEXVERAPAMIL AS RESISTANCE MODULATOR IN A NTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER - INTERIM RESULT OF A PHASE-II STUDY
Authors: KROGER N MROSS K GIESEKING F LEHNERT M THURLIMANN B SCHULLER J KUPPER H HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL AS RESISTANCE MODULATOR IN A NTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER - INTERIM RESULT OF A PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 95-95
Risultati: 1-8 |